← All drafts
Draft #3153 quality rejected Created May 1, 2026, 21:46:01

Pipeline run for this draft

Generated note

Ozempic’s FDA label does not list “bone shedding” as an official adverse reaction. A 2024 64-person trial found lower hip/spine bone density and higher bone resorption with semaglutide, saying this may be explained by weight loss. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209637s025lbl.pdf https://pmc.ncbi.nlm.nih.gov/articles/PMC11087719/

Source post

If only there were signs… https://t.co/TOlmtSfO1F

May 1, 2026, 14:03:06 Open on X →

Pipeline steps

6 steps
  1. ✓
  2. ✓
  3. ✓
  4. ✓
  5. –
  6. ✕
Step #1

generate_note.pre_filter

Success
Started
May 1, 2026, 21:46:01
Finished
May 1, 2026, 21:48:08
Duration
—

Input snapshot

{
  "post_text": "[Target Post]\nIf only there were signs… https://t.co/TOlmtSfO1F\n(This post has 1 attached image(s))"
}

Output snapshot

{
  "has_factual_claims": true
}